DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergency

The record

Jurisdiction

United States (federal); Drug Enforcement Administration, Diversion Control Division

Level

Federal

Authority

21 C.F.R. 1307.03; exception to 21 C.F.R. 1301.12 (separate registration in each State)

Issued

2020-03-25 Mar. 25, 2020

Effective

2020-03-25

End

For the duration of the public health emergency declared Jan. 31, 2020

In force

Mar. 25, 2020 (no end date recorded; counted as in force for 120 days)

Quarters

2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3

2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3

Limitation types

Telework mandateHealth care ordersOther

Addressees

• DEA registrants (practitioners)

Functions reached

• TM telehealth across State lines
• HR credentialing and travel practitioners
• CL clinical

Collection

Other federal health agencies AGY-FED-HEALTH-OTHER

Operative words

in view of the extraordinary circumstances that have arisen during this public health emergency, and in order to ensure adequate medical care for the duration of this public health emergency, DEA will grant an exception for practitioners in such states to those provisions of DEA regulations that normally require practitioners to register in each state where they dispense controlled substances.... DEA-registered practitioners are not required to obtain additional registration(s) with DEA in the additional state(s) where the dispensing (including prescribing and administering) occurs, for the duration of the public health emergency declared on January 31, 2020, if authorized to dispense controlled substances by both the state in which a practitioner is registered with DEA and the state in which the dispensing occurs.

Enforcement

Notes